Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
50
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biomerica Inc. market cap is $6.25M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biomerica Inc. 52 week high is $2.94 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biomerica Inc. 52 week low is $1.27 as of November 17, 2026.
Biomerica Inc. stock price today is $1.32.
Biomerica Inc. stock price yesterday was $1.36.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biomerica Inc.'s P/E ratio is -0.81.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biomerica Inc. P/B ratio is 1.6641.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biomerica Inc. 50-day moving average is $1.96.